NeoGenomics Inc (NEO)
15.46
+0.10
(+0.65%)
USD |
NASDAQ |
Nov 21, 14:29
NeoGenomics Price: 15.46 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 15.29 | 15.49 | 15.04 | 15.36 | 398106.0 |
| Nov 19, 2024 | 14.84 | 15.38 | 14.81 | 15.36 | 375355.0 |
| Nov 18, 2024 | 15.08 | 15.26 | 14.96 | 15.01 | 423621.0 |
| Nov 15, 2024 | 16.00 | 16.02 | 15.01 | 15.04 | 582445.0 |
| Nov 14, 2024 | 16.39 | 16.60 | 15.71 | 15.79 | 681139.0 |
| Nov 13, 2024 | 16.49 | 16.56 | 16.24 | 16.43 | 676473.0 |
| Nov 12, 2024 | 16.14 | 16.54 | 16.03 | 16.33 | 706610.0 |
| Nov 11, 2024 | 15.97 | 16.45 | 15.76 | 16.35 | 975755.0 |
| Nov 08, 2024 | 15.79 | 15.94 | 15.45 | 15.77 | 1.133M |
| Nov 07, 2024 | 15.47 | 15.98 | 15.32 | 15.82 | 940050.0 |
| Nov 06, 2024 | 15.68 | 15.80 | 14.87 | 15.46 | 1.246M |
| Nov 05, 2024 | 13.55 | 15.08 | 13.35 | 14.93 | 1.661M |
| Nov 04, 2024 | 13.91 | 14.20 | 13.91 | 14.14 | 929561.0 |
| Nov 01, 2024 | 13.70 | 14.33 | 13.66 | 14.00 | 1.117M |
| Oct 31, 2024 | 13.38 | 13.67 | 13.21 | 13.59 | 700197.0 |
| Oct 30, 2024 | 13.37 | 13.71 | 13.37 | 13.49 | 431820.0 |
| Oct 29, 2024 | 13.41 | 13.81 | 13.37 | 13.52 | 466637.0 |
| Oct 28, 2024 | 13.17 | 13.54 | 13.17 | 13.48 | 358706.0 |
| Oct 25, 2024 | 13.14 | 13.27 | 12.99 | 13.07 | 490204.0 |
| Oct 24, 2024 | 13.11 | 13.27 | 12.96 | 13.05 | 744705.0 |
| Oct 23, 2024 | 13.11 | 13.25 | 12.85 | 13.07 | 731904.0 |
| Oct 22, 2024 | 13.14 | 13.34 | 13.01 | 13.22 | 791726.0 |
| Oct 21, 2024 | 13.50 | 13.50 | 13.08 | 13.13 | 481225.0 |
| Oct 18, 2024 | 13.59 | 13.64 | 13.39 | 13.56 | 538753.0 |
| Oct 17, 2024 | 13.75 | 13.81 | 13.42 | 13.50 | 628411.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.45
Minimum
Oct 21 2022
59.88
Maximum
Feb 12 2021
24.95
Average
17.90
Median
Mar 10 2022
Price Benchmarks
| Bruker Corp | 56.05 |
| Henry Schein Inc | 73.26 |
| Karyopharm Therapeutics Inc | 0.7744 |
| Apellis Pharmaceuticals Inc | 27.44 |
| Beam Therapeutics Inc | 24.00 |
Price Related Metrics
| PS Ratio | 3.033 |
| Price to Book Value | 2.185 |
| Earnings Yield | -3.95% |
| Market Cap | 1.984B |